title: [Effect of different angiotensin converting enzyme inhibitors on coronary collateral circulation].
abstract: OBJECTIVE
  To observe the effects of different angiotensin converting enzyme inhibitors (ACEI) on coronary collateral circulation.
  
  
  METHODS
  Twenty-four healthy dogs underwent measurement of distolic aortic pressure (DAP) and ligation of the left anterior descending coronary artery. The distolic coronary pressure (DCP) and retrograde blood flow (Qret) were measured. Five days after the operation the dogs were randomly divided into three groups of 8 dogs: benazepril group (benazepril 10 mg qd); captopril group (captopril 12.5 mg bid) and control group (starch tablet was given). Thirty days after the operation a reflux catheter was inserted to measure the DCP and Qret again. Then the dogs were killed and their hearts were taken out to examine the pathologic changes. The angiotensin converting enzyme (ACE) activity levels in plasma and myocardium were examined by FAPGG spectrophotometry.
  
  
  RESULTS
  (1) In the captopril group the plasma ACE activity was (24.1 +/- 0.6) U/L 10 days after medication, and 24.3 +/- 0.6 U/L twenty-five days after medication, both significantly lower than that before medication [(57.6 +/- 0.8) U/L, both P < 0.01]; in benazepril group the plasma ACE activity was (24.4 +/- 0.4) U/L ten days after medication, and (24.0 +/- 0.5) U/L 25 days after medication, both significantly lower than that before medication [(59.5 +/- 1.3) U/L, both P < 0.01]. The plasma ACE activity levels of captopril and benazepril groups, especially of the benazepril group, after medication were significantly lower than that of the control group. The tissue ACE activity levels of the captopril and benazepril groups were lower than that of the control group. (2) The values of DCP in the control and captopril group were higher after medication than before medication. A tendency of decrease of DCP was shown in the benazepril group, however, without statistical significance. (3) In the control group Qcol was (2.01 +/- 0.31) ml/min 25 days after medication, significantly than that before medication [(0.91 +/- 0.15) ml/min], the corresponding values in captopril group were (2.24 +/- 0.46) ml/min and (0.88 +/- 0.13) ml/min respectively in the captopril group and (3.18 +/- 0.27) ml/min and (0.89 +/- 0.11) ml/min respectively in the benazepril group with the value 25 days after in the benazepril group being the highest. (4) 30 days after operation collateral circulation was established in the ischemic myocardium in all 3 groups. The microvessel density in the ischemic zone of myocardium was higher than that in the nonischemic zone in all 3 groups. The microvessel density in the ischemic zone of myocardium was greater in the benazepril group than in the captopril and control groups. There was no difference in microvessel density between the captopril group and control group.
  
  
  CONCLUSIONS
  Benazepril increases the microvessel density and collateral flow, promotes the creation of collateral circulation in ischemic area, but captopril has not such effects.
authors.affiliation: Department of Cardiology, Shandong Provincial Hospital, Jinan 250021, China.
authors.forename: Xing-hua
authors.initials: XH
authors.lastname: Zhang
authors.forename: Xiao-jing
authors.initials: XJ
authors.lastname: Ma
authors.forename: Ji
authors.initials: J
authors.lastname: Luo
authors.forename: Jian-hua
authors.initials: JH
authors.lastname: Shao
authors.forename: Qing-xin
authors.initials: QX
authors.lastname: Geng
authors.forename: Xing-lei
authors.initials: XL
authors.lastname: Zhu
authors.forename: Yuan-sheng
authors.initials: YS
authors.lastname: Tang
authors.forename: Fa-yun
authors.initials: FY
authors.lastname: Xu
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D002216:Captopril / Q000494:pharmacology; D003097:Collateral Circulation / Q000187:drug effects*; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D005260:Female; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011897:Random Allocation; D013050:Spectrometry, Fluorescence
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001552:Benzazepines; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; C044946:benazepril